localnews.ie

Merck KGaA refused Supreme Court appeal over stay of Irish trademark claims

By Fionn Kelly

Historic decision · Decision date:

The Court of Appeal had paused Merck's trademark and passing off claims against Merck Sharp & Dohme Ireland (Human Health) because of related proceedings in Germany.

The Supreme Court refused Merck KGaA and four related companies leave to appeal a Court of Appeal decision on 19 February 2026. The ruling had stayed their Irish trademark infringement and passing off claims against Merck Sharp & Dohme Ireland (Human Health) Limited.

The applicants are Merck KGaA, Merck Serono (Ireland), Merck Millipore, Sigma-Aldrich Ireland and Versum Materials Ireland. The respondents are Merck Sharp & Dohme LLC and its Irish company.

Both sides share the name Merck, but the text describes them as different entities with a common origin. A 1955 co-existence agreement, renewed in 1970, governs their use of the name, and its meaning is in dispute.

The Court of Appeal, in a judgment of 24 September 2025, stayed the claims under Article 30 of the Recast Brussels Regulation. It found a high risk of irreconcilable judgments because of the German proceedings.

The Supreme Court found no matter of general public importance. It said the ruling applied well-established principles and was partly interlocutory, which makes such an appeal harder to justify.

It added that the applicants' main argument had not been made in the Court of Appeal. It also saw no need for a reference to the Court of Justice of the European Union.

The panel was Justices Dunne, Woulfe and Donnelly.

Sources

Source: Courts Service of Ireland. Read the linked determination for the court’s exact decision.

Request a correction or removal